CYP2C19*4B/*7 AND Citalopram response
- Germline classification:
- drug response (1 submission)
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000783963.10
Allele description [Variation Report for CYP2C19*4B/*7]
NM_000769.1(CYP2C19):c.819+2T>A
NM_000769.1(CYP2C19):c.1A>G (p.Met1Val)
NM_000769.1(CYP2C19):c.-806C>T
Condition(s)
- Name:
- Citalopram response
- Synonyms:
- Celexa response
- Identifiers:
- MedGen: CN221263
Assertion and evidence details
Last Updated: Apr 20, 2024